A Risperdal compensation deal has been agreed ahead of a trial. This is said to be one of many potentially multi-million-pound settlements over the drug.
Some users who have been taking Risperdal medication have suffered severe side-effects. The use of the drug has also been involved in off-label marketing; i.e. using the drug for alternative reasons than what regulators have approved the drug for.
Off-label marketing can be a real problem for consumers. When pharmaceutical giants see slow sales in particular products, they can be tempted to repackage them and sell them for different uses. Sometimes this isn’t a bad thing, but when the drug isn’t approved for certain uses, and where certain side-effects are prominent in off-label uses, people can suffer.
Latest Risperdal compensation case settled before trial
It’s understood that another Risperdal compensation claim has settled before the case has reached trial.
The case is actually for a family in America, where it’s understood that a compensation package has been made available.
Settling on the doors of a trial is actually quite a common thing. With the costs of defending an action through the court process often being high, Defendants are far more likely to settle before it gets too far.
At the end of the day, where there’s a case to answer, they ought to be settling immediately we often find they will wait until the last minute to make a deal.
Severe side-effects lead to Risperdal compensation claims
Severe side-effects have led to thousands of Risperdal compensation claims being made.
The side-effects people have suffered have included:
- Male breast growth;
- Premature puberty in females;
- Heart attacks;
- Weight gain.
Some of the side-effects have reportedly led to serious injuries and even patient deaths. People who have suffered side-effects have launched Risperdal compensation claims. Children of users who have suffered the side-effects have also launched claims as well.
Off-label marketing leads to Risperdal compensation claims
Forms of off-label marketing have led to the surge in Risperdal compensation cases.
Some of the off-label uses have included for anxiety and ADHD.
People in the UK who need advice for Risperdal cases are welcome to contact our team for help and advice today.
First published by Author on November 02, 2018
Posted in the following categories: Group Actions Health Medical and tagged with class actions | compensation claims | medical product | medicinal drugs | prescription drugs | product safety